Clinical Trials

GastrointestinalGenitourinary

150 enrolled

Urinary Bladder Neoplasms, Colorectal Neoplasms

NCT04467021 2026-03-02

Cancer and Blood Pressure Management, CARISMA Study

61 enrolled

Carcinoma, Renal Cell, Cardiovascular Diseases, Carcinoma, Medullary, Renal Insufficiency, Chronic

NCT06040762 2026-03-02

A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial

128 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT07206056 2026-03-02

TulmiSTAR-01

Phase 1/2 Recruiting

188 enrolled

Progressive Metastatic Castrate Resistant Prostate Cancer

NCT06855277 2026-02-24

AcTFirst

Phase 3 Recruiting

940 enrolled

Prostatic Neoplasms

NCT06037863 2026-02-23

Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial

168 enrolled

Prostatic Neoplasms

NCT04876651 2026-02-20

The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only

Phase 3 Terminated

16 enrolled

Phase 1 Active not recruiting

Prostatic Neoplasms

NCT04731376 2026-02-11

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

56 enrolled

GastrointestinalGenitourinaryThoracic

Hypogonadism, Urologic Diseases, Urologic Neoplasms

NCT06563388 2026-02-04

ID-COMET

Phase 3 Recruiting

800 enrolled

Colonic Neoplasms, Lung Neoplasms, Prostatic Neoplasms

NCT07218718 2026-01-28

Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy

60 enrolled

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07126548 2026-01-20

A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men

200 enrolled

Prostatic Neoplasms

NCT06296147 2026-01-16

Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy

208 enrolled

Prostatic Neoplasms

NCT04870515 2026-01-09

Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study

Phase NA Completed

20 enrolled 12 charts

Localized Prostate Carcinoma

NCT03151629 2026-01-06

IRONMAN

Recruiting

5,000 enrolled

Prostatic Neoplasms

NCT05519878 2025-12-24

Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

224 enrolled

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT04905082 2025-12-11

HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics

BreastGastrointestinalGenitourinaryGynecologicThoracic

465 enrolled 11 charts

Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT03523338 2025-12-10

An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer

No longer available

Prostatic Neoplasms

NCT07087860 2025-12-09

RECIPE-B1

70 enrolled

Phase EARLY_PHASE1 Active not recruiting

Urinary Bladder Neoplasms, Ureteral Neoplasms

NCT03511196 2025-12-04

Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer

17 enrolled

Prostatic Neoplasms

NCT03784755 2025-11-20

PLATON

409 enrolled

Prostate Cancer Metastatic

NCT06046131 2025-11-17

KP-CARAIBES

3,000 enrolled

Adenocarcinoma, Neoplasm Metastasis, Prostatic Neoplasms, Recurrence

NCT05454488 2025-11-14

An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer

30 enrolled

Phase EARLY_PHASE1 Completed

Prostatic Neoplasms

NCT03734653 2025-11-06

Testosterone Therapy in Castration Resistant Prostate Cancer

30 enrolled

Prostatic Neoplasms

NCT06014255 2025-10-29

HEAT

219 enrolled

Prostatic Neoplasms

NCT05487846 2025-10-10

Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation

120 enrolled

Prostatic Neoplasms

NCT05754658 2025-10-06

African Cancer Genome: GMD

Recruiting

1,500 enrolled

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT06391099 2025-09-30

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

DermatologicGenitourinary

60 enrolled

Carcinoma, Renal Cell, Melanoma

NCT03075423 2025-09-26

Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC

Phase 2 Completed

316 enrolled

Carcinoma, Renal Cell

NCT04763915 2025-09-19

IMPACT

BreastGastrointestinalGenitourinaryGynecologic

720 enrolled

Breast Neoplasms, Neoplastic Syndromes, Hereditary, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT03232541 2025-08-24

The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting

Phase NA Completed

198 enrolled

BreastGastrointestinalGenitourinary

Urinary Bladder Neoplasms, Breast Neoplasms, Vomiting, Colorectal Neoplasms

NCT07135271 2025-08-22

BeSpoke

Phase NA Not yet recruiting

346 enrolled

Localised Prostate Cancer

NCT07126860 2025-08-17

ZMoveMent-1

150 enrolled

Psychological Well-Being, Motor Activity, Prostatic Neoplasms

NCT06401980 2025-08-14

Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

162 enrolled

Metastatic Castration-resistant Prostate Cancer

NCT07053462 2025-07-08

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

Phase 1/2 Recruiting

90 enrolled

Carcinoma, Renal Cell, Kidney Failure, Chronic, Renal Insufficiency

NCT06903312 2025-07-03

ITALIC-RCC

Phase 4 Recruiting

409 enrolled

Phase 3 Active not recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04115007 2025-06-26

Oligo-PRESTO

550 enrolled

GastrointestinalGenitourinaryThoracic

Oligometastatic Hormone Sensitive Prostate Cancer

NCT05801965 2025-05-25

A Digital Therapeutic Solution for Cancer Patients

Phase NA Completed

48 enrolled

Lung Neoplasms, Motor Activity, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Medication Adherence

NCT03582774 2025-05-13

PSMA SRT

Phase 3 Active not recruiting

193 enrolled